The Boeing Co. (BA) is Trading Lower on Unusual Volume for February 11

Equities Staff |

The Boeing Co. (BA) experienced unusually high volume on Feb. 11, as the stock lost 6.94% to a closing price of $108.28. The stock saw 29.37 million shares trade hands over the course of the day on 182,393 trades. Given that the stock’s average daily volume over the last month has been 6.43 million shares a day, this represents a pretty substantial spike over the norm.

The Boeing Co. has a P/B ratio of 10.76. It also has a P/E ratio of 15.6. The stock has traded between $158.83 and $115.02 over the last 52-weeks, its 50-day SMA is now $133.44, and its 200-day SMA $137.57.

Boeing Co, together with its subsidiaries designs, develops, manufactures, sells, services and supports commercial jetliners, military aircraft, satellites, missile defense, human space flight and launch systems and services.

Headquartered in Chicago, IL, The Boeing Co. has 165,500 employees and is currently under the leadership of CEO Dennis A. Muilenburg.

For a complete fundamental analysis analysis of The Boeing Co., check out’s Stock Valuation Analysis report for BA. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…

Initial State

Initial State is an Internet of Things (IoT) data analytics & data management platform company. We turn sensor and event data into information that matters by making it easy to…